The genomics upstart is struggling to move from the research market, where it has few advantages, to the clinical one, where it might have more.

Who Backed this News


NewsMeBack is the place for everyone who likes citizen journalism and social news, a place for you where you can put your news, events from everyday life, something interesting that happened in your life or else.